Characteristics of isolated CD4+CD25+ T-cell clones
| Clone . | Clone derived from . | Genomic location of dominant integration site, hg 18* . | Proviral load composed of dominant integration site, % . |
|---|---|---|---|
| 1 | Asymptomatic carrier 1 | Chromosome 6: 84613188 | 98.95 |
| 2 | Asymptomatic carrier 1 | Chromosome 1: 184745603 | 99.95 |
| 3 | HAM/TSP patient 1 | Chromosome 16: 52158560 | 99.9 |
| 4 | HAM/TSP patient 1 | Chromosome X: 114257179 | 99.9 |
| 5 | HAM/TSP patient 1 | Chromosome 10: 2277787 | 100 |
| 6 | HAM/TSP patient 1 | Chromosome 13: 74997821 | 98.88 |
| 7 | HAM/TSP patient 2 | Chromosome 10: 80828281 | 99.96 |
| 8 | HAM/TSP patient 2 | Chromosome 5: 1997980 | 99.9 |
| 9 | HAM/TSP patient 2 | Chromosome 4: 70601874 | 95.2 |
| 10 | HAM/TSP patient 2 | Chromosome X: 129048967 | 100 |
| 11 | HAM/TSP patient 2 | Chromosome 14: 45274700 | 100 |
| 12 | HAM/TSP patient 3 | Chromosome 4: 107219655 | 99.9 |
| 13 | HAM/TSP patient 3 | Chromosome 12: 40920384 | 100 |
| 14 | HAM/TSP patient 4 | Chromosome 5: 50609660 | 98.4 |
| 15 | HAM/TSP patient 4 | Chromosome 3: 76576960 | 99.9 |
| 16 | HAM/TSP patient 4 | Chromosome 19: 32974427 | 100 |
| 17 | HAM/TSP patient 4 | Chromosome 19: 38521388 | 100 |
| 18 | HAM/TSP patient 4 | Chromosome 14: 80728657 | 95.5 |
| 19 | HAM/TSP patient 4 | Chromosome 4: 169472575 | 100 |
| 20 | HAM/TSP patient 5 | Chromosome 3:75952018 | 100 |
| 21 | Polymyositis patient 1 | Chromosome 2: 214080658 | 99.95 |
| 22 | Polymyositis patient 1 | Chromosome 6: 167451858 | 99.9 |
| 23 | Polymyositis patient 1 | Chromosome 22: 31885379 | 100 |
| 24 | Polymyositis patient 1 | Chromosome 3: 32582626 | 98.6 |
| 25 | ATLL patient 1 | Chromosome 22: 42654531 | 99.89 |
| 26 | ATLL patient 2 | Chromosome 4: 9905297 | 99.8 |
| 27 | Asymptomatic carrier 2 | Chromosome 8: 87708389 | 52 |
| 27 | Asymptomatic carrier 2 | Chromosome 9: 11420980 | 42 |
| Clone . | Clone derived from . | Genomic location of dominant integration site, hg 18* . | Proviral load composed of dominant integration site, % . |
|---|---|---|---|
| 1 | Asymptomatic carrier 1 | Chromosome 6: 84613188 | 98.95 |
| 2 | Asymptomatic carrier 1 | Chromosome 1: 184745603 | 99.95 |
| 3 | HAM/TSP patient 1 | Chromosome 16: 52158560 | 99.9 |
| 4 | HAM/TSP patient 1 | Chromosome X: 114257179 | 99.9 |
| 5 | HAM/TSP patient 1 | Chromosome 10: 2277787 | 100 |
| 6 | HAM/TSP patient 1 | Chromosome 13: 74997821 | 98.88 |
| 7 | HAM/TSP patient 2 | Chromosome 10: 80828281 | 99.96 |
| 8 | HAM/TSP patient 2 | Chromosome 5: 1997980 | 99.9 |
| 9 | HAM/TSP patient 2 | Chromosome 4: 70601874 | 95.2 |
| 10 | HAM/TSP patient 2 | Chromosome X: 129048967 | 100 |
| 11 | HAM/TSP patient 2 | Chromosome 14: 45274700 | 100 |
| 12 | HAM/TSP patient 3 | Chromosome 4: 107219655 | 99.9 |
| 13 | HAM/TSP patient 3 | Chromosome 12: 40920384 | 100 |
| 14 | HAM/TSP patient 4 | Chromosome 5: 50609660 | 98.4 |
| 15 | HAM/TSP patient 4 | Chromosome 3: 76576960 | 99.9 |
| 16 | HAM/TSP patient 4 | Chromosome 19: 32974427 | 100 |
| 17 | HAM/TSP patient 4 | Chromosome 19: 38521388 | 100 |
| 18 | HAM/TSP patient 4 | Chromosome 14: 80728657 | 95.5 |
| 19 | HAM/TSP patient 4 | Chromosome 4: 169472575 | 100 |
| 20 | HAM/TSP patient 5 | Chromosome 3:75952018 | 100 |
| 21 | Polymyositis patient 1 | Chromosome 2: 214080658 | 99.95 |
| 22 | Polymyositis patient 1 | Chromosome 6: 167451858 | 99.9 |
| 23 | Polymyositis patient 1 | Chromosome 22: 31885379 | 100 |
| 24 | Polymyositis patient 1 | Chromosome 3: 32582626 | 98.6 |
| 25 | ATLL patient 1 | Chromosome 22: 42654531 | 99.89 |
| 26 | ATLL patient 2 | Chromosome 4: 9905297 | 99.8 |
| 27 | Asymptomatic carrier 2 | Chromosome 8: 87708389 | 52 |
| 27 | Asymptomatic carrier 2 | Chromosome 9: 11420980 | 42 |
hg 18 indicates human genome build 18 (NCBI build 36).
This column shows the genomic location of the dominant integration site by chromosome and position using hg18 assembly as reference.